In today's quick episode, we talk about our new paper out now in JAMA Network Open titled "The Oncologic Drugs Advisory Committee Votes of April 2021—Implications for the Fate of Accelerated Approval"

ODAC Votes: doi.org/10.1001/jamaoncol.2021.3046

Back us on Patreon! www.patreon.com/plenarysession

Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

In today's quick episode, we talk about our new paper out now in JAMA Network Open titled "The Oncologic Drugs Advisory Committee Votes of April 2021—Implications for the Fate of Accelerated Approval" ODAC Votes: doi.org/10.1001/jamaoncol.2021.3046 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021

Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.

A podcast on medicine, oncology, & health policy. 
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Medicine

Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service. A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.

A podcast on medicine, oncology, &amp; health policy. 
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Share 4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021

Sign up to save your podcasts

4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021

4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021

More shows like Plenary Session - inactive due to federal service

NEJM This Week

The Glenn Show

Making Sense with Sam Harris

JAMA Clinical Reviews

The Curbsiders Internal Medicine Podcast

The ZDoggMD Show

Core IM | Internal Medicine Podcast

The Readout Loud

The Peter Attia Drive

Annals On Call Podcast

The VPZD Show

Two Onc Docs

NEJM AI Grand Rounds

Sensible Medicine